Experimental drug given to Trump being tested in Stanford – NBC Bay Area

President Donald Trump is at Walter Reed Medical Center on Friday night less than 24 hours after being diagnosed with COVID-19, and has been given an experimental drug that is currently being tested at Stanford Medical Center.

The clinical trial is so new that Stanford Hospital had received the drug three weeks earlier.

Antibody therapeutic cocktails are believed to help the patient’s immune system fight a COVID-19 infection.

The drug is called Regn COV2. The producer, Regeron, said that for Trump it provides a dose of eight grams.

“He received the highest dose, which appears to be very effective, at least in early studies,” Stanford infectious disease epidemiologist Drs. Yvonne Maldonado said.

Maldonado is the doctor who is participating in the clinical trials.

The drug is a cocktail of something called monoclonal antibodies. Since the drug is very new, there is not much data regarding its long-term effectiveness.

Moldado and other colleagues with extensive experience treating COVID-19 patients said that the president has a number of risk factors for severe infections, including his age, weight and cholesterol.

They are particularly concerned about how quickly their symptoms have progressed.

Just a few days ago, Trump did not have symptoms. By Thursday he was ill, and by Friday he had a fever and went to the hospital.

Trump, who is generally active on Twitter, sent just one tweet to Walter Reid.

“It’s going well, I think.” thanks all. Love, ”read the tweet.


Leave a Reply